CNN-based Identification of Parkinsonian Gait using Ground Reaction Forces | IEEE Conference Publication | IEEE Xplore

CNN-based Identification of Parkinsonian Gait using Ground Reaction Forces


Abstract:

Parkinson's disease is among the most common conditions faced by older people, which causes stiffness and slowing of movement. One manifestation of the disorder assumes a...Show More

Abstract:

Parkinson's disease is among the most common conditions faced by older people, which causes stiffness and slowing of movement. One manifestation of the disorder assumes a non-physiological walking pattern characterized by flatfoot strike or toe-to-heel progression. This paper proposes a method to identify Parkinson's disease using Convolutional Neural Networks to classify the ground reaction forces exerted during walking. Bilateral plantar pressure is acquired using three Aidong IMB C20B pressure sensors for each foot. The training database consists of 13 records acquired in clinical environment and an additional 72 records publicly available online in the Gait in Parkinson's Disease database. The signals are pre-processed to obtain 2D images, which are used to train three Convolutional Neural Networks models: MobileNet, ResNet50 and DenseNet121. According to the performance metrics, the results obtained to identify Parkison's disease are remarkable. The best accuracy is 89% and is obtained for the MobileNet model.
Date of Conference: 13-15 July 2022
Date Added to IEEE Xplore: 18 August 2022
ISBN Information:
Conference Location: Prague, Czech Republic
References is not available for this document.

I. Introduction

Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by tremor, rigidity, difficulty of walking, balance, and coordination [1]. PD is a common neurological ailment having symptoms that appear from the beginning of the disease and intensify over time. The global incidence of PD increased from 2.5 million in 1990 to 6.1 million in 2016 [2], accounting for a 21.7% increase of the age-standardized rate of prevalence [3], [4]. One million people have PD in the US alone, and the number is expected to reach 1.2 million by 2030 [5].

References is not available for this document.

References

References is not available for this document.